Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited)

v3.22.2
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Common Stock
Additional Paid in Capital
Retained Earnings/Accumulated (Deficit)
Beginning Balances at Dec. 31, 2020 $ 40,038,891 $ 93,431 $ 40,455,409 $ (509,949)
Beginning Balance, shares at Dec. 31, 2020   9,343,118    
Restricted stock grants issued   $ 635 (635)  
Restricted stock grants issued, Shares   63,475    
Stock-based compensation 31,706   31,706  
Net income 411,247     411,247
Dividends (607,303)     (607,303)
Ending Balance at Mar. 31, 2021 39,874,541 $ 94,066 40,486,480 (706,005)
Ending Balance, shares at Mar. 31, 2021   9,406,593    
Beginning Balances at Dec. 31, 2020 40,038,891 $ 93,431 40,455,409 (509,949)
Beginning Balance, shares at Dec. 31, 2020   9,343,118    
Net income 1,272,546      
Ending Balance at Jun. 30, 2021 46,362,772 $ 107,086 46,712,620 (456,934)
Ending Balance, shares at Jun. 30, 2021   10,708,613    
Beginning Balances at Mar. 31, 2021 39,874,541 $ 94,066 40,486,480 (706,005)
Beginning Balance, shares at Mar. 31, 2021   9,406,593    
Restricted stock grants issued   $ 123 (123)  
Restricted stock grants issued, Shares   12,300    
Issuance of common stock, net of expenses 6,184,684 $ 12,897 6,171,787  
Issuance of common stock, net of expenses, Shares   1,289,720    
Stock-based compensation 54,476   54,476  
Net income 861,299     861,299
Dividends (612,228)     (612,228)
Ending Balance at Jun. 30, 2021 46,362,772 $ 107,086 46,712,620 (456,934)
Ending Balance, shares at Jun. 30, 2021   10,708,613    
Beginning Balances at Dec. 31, 2021 $ 47,118,097 $ 107,086 46,851,360 159,651
Beginning Balance, shares at Dec. 31, 2021 10,708,613 10,708,613    
Restricted stock grants issued   $ 260 (260)  
Restricted stock grants issued, Shares   26,025    
Restricted stock grant forfeitures, shares   (203)    
Restricted stock grant forfeiture   $ (2) 2  
Issuance of common stock, net of expenses $ 198,370 $ 659 197,711  
Issuance of common stock, net of expenses, Shares   65,843    
Stock-based compensation 52,604   52,604  
Net income 283,207     283,207
Dividends (700,339)     (700,339)
Ending Balance at Mar. 31, 2022 46,951,939 $ 108,003 47,101,417 (257,481)
Ending Balance, shares at Mar. 31, 2022   10,800,278    
Beginning Balances at Dec. 31, 2021 $ 47,118,097 $ 107,086 46,851,360 159,651
Beginning Balance, shares at Dec. 31, 2021 10,708,613 10,708,613    
Net income $ 687,407      
Ending Balance at Jun. 30, 2022 $ 47,672,934 $ 109,657 48,125,045 (561,768)
Ending Balance, shares at Jun. 30, 2022 10,965,680 10,965,680    
Beginning Balances at Mar. 31, 2022 $ 46,951,939 $ 108,003 47,101,417 (257,481)
Beginning Balance, shares at Mar. 31, 2022   10,800,278    
Restricted stock grant forfeitures, shares   (406)    
Restricted stock grant forfeiture   $ (4) 4  
Issuance of common stock, net of expenses 985,953 $ 1,658 984,295  
Issuance of common stock, net of expenses, Shares   165,808    
Stock-based compensation 39,329   39,329  
Net income 404,200     404,200
Dividends (708,487)     (708,487)
Ending Balance at Jun. 30, 2022 $ 47,672,934 $ 109,657 $ 48,125,045 $ (561,768)
Ending Balance, shares at Jun. 30, 2022 10,965,680 10,965,680